Carmell Co. (NASDAQ:CTCX) Short Interest Update

Carmell Co. (NASDAQ:CTCX) saw a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 94,200 shares, a decline of 66.8% from the January 31st total of 284,100 shares. Currently, 0.6% of the company’s shares are sold short. Based on an average daily trading volume, of 6,440,000 shares, the days-to-cover ratio is currently 0.0 days.

Carmell Stock Down 2.1 %

CTCX traded down $0.01 during midday trading on Friday, hitting $0.24. The company’s stock had a trading volume of 214,907 shares, compared to its average volume of 8,762,678. The firm has a 50-day moving average price of $0.37 and a two-hundred day moving average price of $0.40. Carmell has a 52-week low of $0.20 and a 52-week high of $3.35.

Institutional Trading of Carmell

A hedge fund recently bought a new stake in Carmell stock. Antara Capital LP purchased a new stake in Carmell Co. (NASDAQ:CTCX) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 100,000 shares of the company’s stock, valued at approximately $28,000. Carmell accounts for 0.0% of Antara Capital LP’s holdings, making the stock its 10th biggest position. Antara Capital LP owned approximately 0.48% of Carmell at the end of the most recent quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.